Battery X Metals Presents Positive Preliminary Lithium-Ion Battery Rebalancing Trial Results Demonstrating Significant Estimated Driving Range Improvements and Accelerated Commercialization Progress of its Patent-Pending Lithium-Ion Battery Rebalancing Technology Platform

2026-07-11

CSE - Canadian National Stock Exchange · Lithium · Tantalum · Cesium · Rubidium · Tin · Gold · Copper · Canada

News Release Highlights:

Battery X Metals' patent-pending lithium-ion battery rebalancing platform has demonstrated positive preliminary estimated driving range improvements of up to approximately 255 kilometres across real-world electric vehicle performance trials, supporting meaningful battery capacity recovery, advanced diagnostics, sustained performance recovery, and validation across multiple commercial and passenger EV platforms.

The Company has strengthened its intellectual property portfolio through the completion of its International Patent Cooperation Treaty (PCT) patent application, preserving priority rights while establishing a pathway to pursue patent protection in more than 150 countries. Concurrently, Battery X Metals has completed or is actively advancing compatibility development across five strategic electric vehicle platforms, including the Nissan Leaf, Tesla Model 3 and Model Y, Hyundai Ioniq, Chevrolet Volt, and the VMC 1200 electric truck.

Battery X Metals is accelerating commercialization through the advancement of an integrated EV battery diagnostics platform utilizing an onboard diagnostics (OBD-II) interface, together with the continued development of its Rebalancing Machine hardware and software ecosystem, including wireless connectivity, standardized battery health reporting, commercial hardware refinements, and UL certification initiatives, positioning its patent-pending lithium-ion battery rebalancing technology platform for broader commercial deployment as millions of electric vehicles are expected to transition beyond their original battery warranty coverage.

VANCOUVER, BC / ACCESS Newswire/ July 10, 2026 / Battery X Metals Inc. (CSE:BATX)(OTCQB:BATXF)(FSE:5YW0)(WKN:A41RJF) ("Battery X Metals" or the "Company") an energy transition resource exploration and technology company, announces a comprehensive commercialization update for its patent-pending lithium-ion battery rebalancing technology platform, highlighting preliminary performance validation achieved through a series real-world electric vehicle performance trials, together with initiatives intended to accelerate commercialization and broader market deployment.

Over the past twelve months, Battery X Metals has systematically advanced the development and validation of its patent-pending lithium-ion battery rebalancing technology platform through a series of real-world vehicle performance trials and multi-platform evaluations. What began as validation of the Company's core battery rebalancing technology has progressively expanded to demonstrate integrated battery diagnostics, targeted corrective intervention, sustained long-term performance recovery, and applicability across multiple electric vehicle platforms.

Collectively, these preliminary validation milestones have established an important technical foundation supporting the Company's transition from technology validation toward commercialization. As electric vehicle adoption continues to accelerate globally and an increasing number of vehicles begin to exit original battery warranty coverage, Battery X Metals believes demand for technologies capable of extending battery lifespan, restoring usable battery capacity and reducing total cost of ownership will continue to grow.

Accordingly, the Company is now advancing the next phase of development by accelerating commercialization initiatives intended to support manufacturing readiness, expand vehicle compatibility, strengthen strategic industry relationships and position the Rebalancing Machine for broader commercial deployment.

In parallel with these technical and commercialization advancements, and as previously disclosed in the Company's news releasedated April 21, 2026, the Company completed a significant intellectual property milestone through the filing of an International patent application under the Patent Cooperation Treaty ("PCT"). The PCT application preserves priority rights from the Company's previously filed U.S. provisional patent applications with the United States Patent and Trademark Office (USPTO) while establishing a pathway to pursue patent protection in more than 150 countries. The Company believes this milestone enhances the long-term defensibility of its proprietary technology platform and provides an important foundation to support future commercialization, licensing opportunities, strategic partnerships, and international market expansion.

Performance Validation of Patent-Pending Lithium-Ion Battery Rebalancing Machine

Battery X Metals, through its wholly-owned subsidiary, Battery X Rebalancing Technologies Inc., has developed a next-generation, patent-pending lithium-ion battery rebalancing platform (the "Rebalancing Machine") designed to restore usable battery capacity lost through naturally occurring lithium-ion cell imbalance, extend the remaining useful life of electric vehicle ("EV") battery packs, and reduce the need for premature battery replacement. Through a series of real-world performance trials, the Rebalancing Machine has demonstrated measurable improvements in battery capacity utilization, driving range, diagnostic capability, and long-term performance retention across multiple EV platforms, supporting the Company's commercialization strategy.

[](https://app.accessnewswire.com/imagelibrary/c9e33666-ae44-4376-928f-3ea90e106fda/1189757/car.png)

As disclosed in the Company's news releases dated July 4, July 25and October 24, 2025, and January 13and May 22, 2026, the Company completed a series of real-world driving performance trials (each, a "Trial," and collectively, the "Trials") and, in the case of the May 22, 2026news release, reported the results of lithium-ion battery rebalancing trials conducted by multiple international arm's-length third-party automotive service centres utilizing the Company's patent-pending Rebalancing Machine. Collectively, these Trials evaluated the Rebalancing Machine across progressively broader operating conditions, battery chemistries and electric vehicle platforms.

The initial two Trials evaluated the Rebalancing Machine on severely degraded Class 3 commercial electric vehicles (each, an "Electric Truck") exhibiting significant battery capacity loss resulting from naturally occurring lithium-ion cell imbalance. As disclosed in the Company's July 4, 2025 news release, the first Trial demonstrated the Rebalancing Machine's ability to restore a severely degraded battery pack from a reported estimated driving range of approximately 40 kilometres to an estimated 295 kilometres under no-load conditions following completion of a full battery rebalancing procedure, representing an increase of approximately 255 kilometres, or approximately 637%. Importantly, the restored estimated driving range closely approximated the manufacturer's reported operating range for the platform, demonstrating the technology's ability to recover substantial usable battery capacity without requiring battery pack replacement while supporting a lower-cost battery recovery solution for commercial fleet operators.

As disclosed in the Company's July 25, 2025 news release, the second Trial expanded validation by demonstrating the Rebalancing Machine's integrated battery diagnostic capabilities. During the evaluation, the Rebalancing Machine identified a defective battery cell exhibiting abnormal self-discharge within a parallel-connected cell group that had caused premature vehicle shutdown below approximately 60% state of charge ("SOC"). Following targeted replacement of the affected cell group and completion of a battery rebalancing procedure, the Electric Truck's effective driving range increased from approximately 40 kilometres to an estimated 265 kilometres under no-load conditions, representing an increase of approximately 225 kilometres, or approximately 563%. Beyond the recovery in driving range, the Trial demonstrated the Rebalancing Machine's ability to combine advanced battery diagnostics with targeted corrective intervention, supporting the potential for selective battery repair strategies as an alternative to complete battery pack replacement where appropriate.

As disclosed in the Company's October 24, 2025 news release, the Company subsequently completed a follow-up validation assessment of the second Electric Truck to evaluate the durability of the performance improvements observed during the July 2025 Trial. Following approximately four months and more than 2,000 kilometres of continued real-world operation, the vehicle maintained stable range performance, achieving an estimated driving range of approximately 250 kilometres under comparable testing conditions and a weighted average effective driving range of approximately 220 kilometres per full charge over approximately 92% cumulative state of charge utilization. These results demonstrated that the battery performance improvements achieved through the targeted intervention and rebalancing procedure were substantially maintained over time, supporting the Rebalancing Machine's potential to deliver sustained battery performance recovery and extend the remaining useful life of commercial EV battery packs.

As disclosed in the Company's January 13, 2026 news release, the Company further expanded validation through a real-world performance trial on a light-duty electric vehicle equipped with a severely imbalanced 144-cell lithium nickel manganese cobalt oxide (NMC) battery pack that had become effectively inoperable, exhibiting an estimated pre-rebalancing driving range of approximately 0.1 kilometres per charge. Following completion of a full battery rebalancing procedure, the vehicle achieved an average estimated driving range of approximately 135.9 kilometres per charge under mixed driving conditions. The rebalancing process also materially reduced cell-level voltage variance across the battery pack, demonstrating improved battery pack balance, enhanced utilization of existing battery capacity, and the ability to restore meaningful vehicle operability without replacing battery cells.

Further, as disclosed in the Company's May 22, 2026 news release, the Company announced the results of a series of lithium-ion battery rebalancing trials conducted by multiple international arm's-length third-party automotive service centres on multiple electric vehicle platforms manufactured by BYD Company Limited ("BYD") utilizing the Company's next-generation, patent-pending Rebalancing Machine. The evaluations demonstrated estimated driving range improvements of up to approximately 84 kilometres per charge across BYD Song, Seal and Han vehicle platforms, supporting the repeatability of the Rebalancing Machine across multiple high-volume EV platforms and further demonstrating its commercial applicability within one of the world's largest electric vehicle ecosystems.

Collectively, these preliminary validation activities demonstrate the Rebalancing Machine's ability to restore usable battery capacity lost through naturally occurring lithium-ion cell imbalance, integrate advanced battery diagnostics to identify cell-level defects requiring targeted corrective intervention, sustain recovered battery performance under continued real-world operation, and deliver measurable performance improvements across multiple electric vehicle platforms and battery configurations.

The Company believes these preliminary validation milestones establish an important technical foundation supporting the continued commercialization of its patent-pending lithium-ion battery rebalancing technology platform across an expanding range of electric vehicle platforms and operating environments, as the global population of out-of-warranty electric vehicles is anticipated to grow and demand is anticipated to increase for battery lifespan extension solutions that reduce total cost of ownership.

Platform Expansion Supporting Commercialization Initiatives

A foundational component of the Company's commercialization strategy is the systematic expansion of the Rebalancing Machine's compatibility across high-volume electric vehicle battery platforms. Through its ongoing research and development program, Battery X Metals continues to advance the engineering of proprietary battery adaptors and connector solutions designed to enable the Rebalancing Machine to physically interface with an expanding range of lithium-ion battery architectures commonly found in out-of-warranty electric vehicles. The Company believes this platform-by-platform compatibility strategy is fundamental to supporting broad commercial deployment of its patent-pending lithium-ion battery rebalancing technology.

The Company announces that it has successfully completed development of a proprietary battery adaptor providing compatibility across all North American Nissan Leaf battery configurations. The Nissan Leaf was among the world's earliest mass-market battery electric vehicles and remains one of the largest populations of aging battery electric vehicles in North America. Since its launch in December 2010, more than 650,000 Nissan Leaf vehicles have been sold globally,1including 114,808 vehicles sold in the United States between 2010 and 2017, where it ranked as the second best-selling plug-in electric vehicle during that period.2As these vehicles continue transitioning beyond their original battery warranty coverage, the Company believes they represent a substantial and growing addressable market for battery diagnostics, rebalancing and battery lifespan-extension solutions, and that compatibility with the Nissan Leaf platform represents an important commercialization milestone supporting future deployment into the growing battery lifecycle extension market.

The Company further announces that it has commenced adaptor engineering initiatives targeting the Hyundai Ioniq and Chevrolet Volt battery platforms. As part of these initiatives, the Company's technical team completed detailed battery interface measurements and dimensional characterization of both battery systems. The resulting engineering data has been provided to the Company's strategic development partner, Beijing Pengneng Science & Technology Ltd., to support the design and engineering of proprietary adaptor and connector solutions intended to enable compatibility with the Rebalancing Machine.

The Hyundai Ioniq and Chevrolet Volt represent strategically important electrified vehicle platforms within the North American market. The Chevrolet Volt was among the earliest high-volume plug-in electric vehicles, achieving cumulative global sales of approximately 178,785 vehicles prior to its discontinuation, with approximately 150,049 vehicles (approximately 84%) sold in the United States.3This substantial U.S. vehicle population represents an attractive addressable market as these vehicles continue to age beyond their original battery warranty periods. The original Hyundai IONIQ achieved significant adoption across the United States, Canada and Europe, with approximately 251,742 vehicles sold across these markets through 2022, including approximately 82,264 vehicles in the United States, 16,531 vehicles in Canada and 152,947 vehicles in Europe. The United States represented approximately 32.7% of reported IONIQ sales across these three markets.4As these vehicle populations continue to age beyond their original battery warranty periods, the Company believes they represent attractive platforms for future battery diagnostics, rebalancing and battery lifespan-extension services.

These initiatives build upon the Company's previously announced compatibility development activities targeting the Tesla Model 3 battery platform. As disclosed in the Company's news releasedated January 2, 2026, the Company completed a high-resolution three-dimensional (3D) scan of a Tesla Model 3 battery pack, establishing the foundational digital reference required to engineer proprietary adaptor and connector solutions. Tesla accounted for approximately 45% of U.S. electric vehicle sales in 2024,5while cumulative Tesla Model 3 sales reached an estimated 2.63 million vehicles globally by the end of the third quarter of 2024.6 As these vehicles continue to age, a growing proportion is expected to transition beyond their original battery warranty coverage, increasing the addressable market for battery diagnostics, rebalancing and battery lifespan extension technologies.

In addition to these consumer vehicle platforms, the Company has completed development of a proprietary battery adaptor for the VMC 1200 Class 3 commercial electric truck platform. This compatibility supported the Company's previously disclosed commercial vehicle validation activities and further demonstrates the applicability of the Rebalancing Machine across both commercial fleet and passenger electric vehicle battery platforms.

Collectively, these initiatives reflect a deliberate, platform-by-platform commercialization strategy designed to systematically expand the addressable market for the Rebalancing Machine across both commercial fleet and consumer electric vehicle markets.

Current Platform Compatibility Roadmap

By progressively expanding compatibility across high-volume electric vehicle battery architectures, the Company believes it is establishing the technical foundation necessary to support broader commercial deployment of its patent-pending lithium-ion battery rebalancing technology platform. As additional vehicle platforms are incorporated into the Rebalancing Machine ecosystem, the Company believes it will continue to expand the addressable market for its battery diagnostics, rebalancing and battery lifespan extension solutions.

Accelerated Commercialization Initiatives

Building upon the preliminary validation milestones described herein, the Company is advancing a series of commercialization initiatives intended to strengthen its product offering, support commercial readiness, and establish the operational framework necessary for broader market deployment of its patent-pending lithium-ion battery rebalancing technology platform.

Battery Diagnostics as the Front End of the Battery Lifecycle Ecosystem

As part of its broader commercialization strategy, the Company has been evaluating the integration of an advanced EV battery diagnostics platform utilizing an onboard diagnostics (OBD-II) interface, together with a complementary hardware-enabled software platform intended to support battery health assessment and reporting. The Company believes battery diagnostics represent a critical first step in the battery rebalancing process, providing the information necessary to determine whether battery performance degradation may be attributable to lithium-ion cell imbalance prior to recommending corrective intervention.

Through communication with a vehicle's battery management system (BMS), the contemplated diagnostics platform is expected to retrieve and analyze key battery health parameters, including state of health, cell voltages, cell temperature, and other operational metrics relevant to battery condition. These diagnostic outputs are intended to provide automotive service providers with standardized battery health assessments that may assist in identifying battery packs exhibiting characteristics suitable for battery rebalancing.

The Company envisions battery diagnostics serving as the initial customer engagement point within a broader battery lifecycle management ecosystem. Under the Company's anticipated commercial workflow, customers would first receive a battery health assessment through participating automotive service centres utilizing the diagnostics platform. Where battery diagnostics identify cell imbalance as a contributing factor to battery performance degradation, the Rebalancing Machine may subsequently be recommended as a battery recovery solution. The Company believes this complementary diagnostics and battery rebalancing ecosystem has the potential to strengthen customer engagement, enhance service workflows, and support utilization of its battery rebalancing technology. As part of this initiative, the Company is evaluating opportunities to leverage established battery diagnostics technologies, software capabilities and industry expertise to accelerate commercialization while focusing internal development efforts on integration with its proprietary battery rebalancing platform.